Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Salarius Pharmaceuticals, Inc (SLRX)  
$0.61 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 2,280,000
Market Cap: 1.38(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6068 - $0.6068
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Salarius Pharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s pipeline consists of two compounds: seclidemstat (SP-2577), a small molecular inhibitor and SP-3164, a small molecular protein degrader. SP-2577 is a small-molecule lysine specific demethylase 1 (LSD1) inhibitor with a scaffold. LSD1 is an enzyme that is, in part, responsible for epigenetic regulation of genes that support cancer growth. SP-3164 is a cereblon binding molecular glue. SP-3164 degrades transcription factors IKZF1 and IKZF3, along with other proteins, resulting in both direct anti-cancer activity and immune-modulating properties. SP-3164 has activity in both hematologic and solid tumors.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 191,653
Total Buy Value $0 $0 $0 $35,178
Total People Bought 0 0 0 6
Total Buy Transactions 0 0 0 7
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 156
  Page 5 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Sculley John Director   –       •      –    2016-03-18 4 B $11.13 $7,891 I/I 709 709 2.1     -
   Westphal Christoph H President and CEO   •       •       •   2016-03-18 4 B $11.06 $203,913 I/I 18,437 2,862,897 2.64     -
   Westphal Christoph H President and CEO   •       •       •   2016-03-17 4 B $10.94 $209,359 I/I 19,137 2,844,460 2.64     -
   Westphal Christoph H President and CEO   •       •       •   2016-03-16 4 B $10.85 $207,691 I/I 19,142 2,825,323 2.64     -
   Westphal Christoph H President and CEO   •       •       •   2016-03-15 4 B $9.62 $185,060 I/I 19,237 2,806,181 2.64     -
   Stacy Michelle Director   –       •      –    2016-03-15 4 B $9.63 $24,894 D/D 2,585 2,585 2.39     -
   Wessel Thomas Chief Medical Officer   •       –      –    2016-03-14 4 B $9.13 $73,040 D/D 8,000 57,064 2.74     -
   Wessel Thomas Chief Medical Officer   •       –      –    2016-03-11 4 B $7.15 $85,800 D/D 12,000 49,064 2.74     -
   Mackinnon Roderick Director   –       •      –    2016-03-11 4 B $7.03 $70,261 D/D 10,000 431,277 2.39     -
   Westphal Christoph H President and CEO   •       •       •   2016-03-11 4 B $7.00 $627,760 I/I 89,680 2,786,944 2.64     -
   Longwood Fund Ii, L.p. 10% Owner   –       –       •   2016-03-11 4 B $7.00 $627,760 D/D 89,680 2,786,944 2.45     -
   Westphal Christoph H President and CEO   •       •       •   2015-12-14 4 AB $12.01 $11,130 D/D 927 3,925,248     -
   Westphal Christoph H President and CEO   •       •       •   2015-12-07 4 AB $12.02 $10,899 D/D 907 3,924,321     -
   Westphal Christoph H President and CEO   •       •       •   2015-11-30 4 AB $12.32 $10,929 D/D 887 3,923,414     -
   Westphal Christoph H President and CEO   •       •       •   2015-11-23 4 AB $11.39 $11,064 D/D 971 3,922,527     -
   Kozin Marc D Director   –       •      –    2015-11-19 4 B $11.38 $51,219 D/D 4,500 4,500 2.39     -
   Westphal Christoph H President and CEO   •       •       •   2015-11-16 4 AB $10.78 $10,791 D/D 1,001 3,921,556     -
   Westphal Christoph H President and CEO   •       •       •   2015-11-09 4 AB $11.03 $11,032 D/D 1,000 3,920,555     -
   Westphal Christoph H President and CEO   •       •       •   2015-11-02 4 AB $11.59 $11,204 D/D 967 3,919,555     -
   Westphal Christoph H President and CEO   •       •       •   2015-10-26 4 AB $10.55 $11,003 D/D 1,043 3,918,588     -
   Westphal Christoph H President and CEO   •       •       •   2015-10-19 4 AB $10.61 $10,797 D/D 1,018 3,917,545     -
   Westphal Christoph H President and CEO   •       •       •   2015-10-12 4 AB $11.98 $11,072 D/D 924 3,916,527     -
   Westphal Christoph H President and CEO   •       •       •   2015-10-05 4 AB $12.48 $10,833 D/D 868 3,915,603     -
   Westphal Christoph H President and CEO   •       •       •   2015-09-28 4 AB $11.18 $10,335 D/D 924 3,914,735     -
   Westphal Christoph H President and CEO   •       •       •   2015-09-21 4 AB $16.04 $11,757 D/D 733 3,913,811     -

  156 Records found
  1  2  3  4  5  6  7   
  Page 5 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed